| Original language | English (US) |
|---|---|
| Pages (from-to) | 1175-1176 |
| Number of pages | 2 |
| Journal | Pancreas |
| Volume | 47 |
| Issue number | 10 |
| DOIs | |
| State | Published - Nov 1 2018 |
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Hepatology
- Endocrinology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Intercepting pancreatic cancer : Our dream team's resolve to stop pancreatic cancer. / Goggins, Michael G.; Lippman, Scott M.; Constantinou, Pamela E.; Jacks, Tyler; Petersen, Gloria M.; Syngal, Sapna; Maitra, Anirban.
In: Pancreas, Vol. 47, No. 10, 01.11.2018, p. 1175-1176.Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Intercepting pancreatic cancer
T2 - Our dream team's resolve to stop pancreatic cancer
AU - Goggins, Michael G.
AU - Lippman, Scott M.
AU - Constantinou, Pamela E.
AU - Jacks, Tyler
AU - Petersen, Gloria M.
AU - Syngal, Sapna
AU - Maitra, Anirban
N1 - Funding Information: From the *Department of Medicine (Gastroenterology), The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Biostatistics Center; †Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD; ‡Division of Hematology/Oncology, Department of Medicine, Moores Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla, CA; §Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX; ||David H. Koch Institute for Integrative Cancer Research; ¶Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA; #Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN; **Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; ††Department of Medicine, Brigham & Women's Hospital, Boston, MA; and ‡‡Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX. Address correspondence to: Anirban Maitra, MBBS, Sheikh Ahmed Center for Pancreatic Cancer Research, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit #1050, Houston, TX 77030 (e‐mail: amaitra@mdanderson.org). Michael Goggins, Scott M. Lippman, and Pamela E. Constantinou contributed equally to this work. This research is supported by a Stand Up To Cancer (SU2C)–Lustgarten Foundation Pancreatic Cancer Interception Translational Cancer Research Grant (grant no. SU2C-AACR-DT25-17). SU2C is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C. The authors declare no conflict of interest. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved. DOI: 10.1097/MPA.0000000000001165
PY - 2018/11/1
Y1 - 2018/11/1
UR - http://www.scopus.com/inward/record.url?scp=85055073451&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055073451&partnerID=8YFLogxK
U2 - 10.1097/MPA.0000000000001165
DO - 10.1097/MPA.0000000000001165
M3 - Editorial
C2 - 30325853
AN - SCOPUS:85055073451
VL - 47
SP - 1175
EP - 1176
JO - Pancreas
JF - Pancreas
SN - 0885-3177
IS - 10
ER -